USP Releases Medicare Prescription Drug Benefit Model Guidelines

On December 31, 2004, the United States Pharmacopeia (USP) submitted its Medicare Prescription Drug Benefit Model Guidelines (Model Guidelines) to the Centers for Medicare and Medicaid Services (CMS). This document fulfills a cooperative agreement between USP and CMS entered into under the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA). The MMA specifically named USP as the organization charged with developing a list of categories and classes that may be used by plans offering the Medicare drug benefit to develop their formularies.
http://www.onlinepressroom.net/uspharm/